|
Volumn 35, Issue SUPPL. 1, 2000, Pages
|
The potential advantages of a modern antihypertensive therapy in the elderly
|
Author keywords
Clinical trials; Elderly; Hypertension; Lacidipine
|
Indexed keywords
AMILORIDE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BENDROFLUMETHIAZIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CHLORTALIDONE;
DIHYDROPYRIDINE DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FELODIPINE;
LACIDIPINE;
METOPROLOL;
NITRENDIPINE;
PINDOLOL;
TRIAMTERENE;
ADULT;
AGED;
AGING;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FEMALE;
GERIATRIC PATIENT;
HEADACHE;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PHASE 4 CLINICAL TRIAL;
PRESSORECEPTOR REFLEX;
PRIORITY JOURNAL;
STROKE;
TREATMENT OUTCOME;
AGED;
ANTIHYPERTENSIVE AGENTS;
DIHYDROPYRIDINES;
HUMANS;
HYPERTENSION;
|
EID: 0033695232
PISSN: 01602446
EISSN: None
Source Type: Journal
DOI: 10.1097/00005344-200000001-00004 Document Type: Article |
Times cited : (8)
|
References (27)
|